Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement

E-ISSN： 1600-0609|97|4|342-347

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.97, Iss.4, 2016-10, pp. : 342-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Characteristics and Long-Term Outcome of Patients with Systemic Immunoglobulin Light-Chain Amyloidosis

Acta Haematologica, Vol. 133, Iss. 4, 2014-12 ,pp. : 336-346

Karger

Access to resources Recommend Favorite

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 804-813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : E60-E65

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Outcome and Predictors of Clinical Renal Involvement in Patients with Silent Lupus Nephritis

Nephron Clin Pract, Vol. 98, Iss. 4, 2004-12 ,pp. : c105-c111

Karger

Access to resources Recommend Favorite

A rare case of primary systemic amyloidosis presenting with multiorgan involvement

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 6, 2015-06 ,pp. : 1238-1239

John Wiley & Sons Inc

Access to resources Recommend Favorite